Stock listing
Nexien Biopharma, Inc.
Selected listing: NXEN · OTC · USD · US
Nexien Biopharma, Inc. (OTC:NXEN), Health Technology. Latest release Feb 19, 2021: Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public…
- Ticker
- OTC:NXEN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Nexien Biopharma, Inc.
The company focuses on biopharmaceutical development and innovation. Its activities aim to address unmet medical needs through advanced therapeutic solutions.
Latest news from Nexien Biopharma, Inc.
Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
February 19, 2021
Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2
July 16, 2020
Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity - two common nerve agents
July 18, 2019
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
March 27, 2019
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office
March 5, 2019
Research Nexien Biopharma, Inc.
Nexien Biopharma, Inc. company profile
View the public company page for Nexien Biopharma, Inc. on 6ix.
Nexien Biopharma, Inc. news
Read company news and market updates connected to Nexien Biopharma, Inc..
Nexien Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Nexien Biopharma, Inc..